5 completed, 1 unknown. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Vaxine Pty Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Booster Study of SpikoGen COVID-19 Vaccine SpikoGen vaccine - COVID-19 | Phase 3 | Completed | Vaxine Pty Ltd | 81 | 2022-09-07 | 2025-09-17 |
| A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen) Advax-CpG55.2 adjuvanted recombinant spike protein - COVID-19 | Phase 3 | Completed | Vaxine Pty Ltd | 39 | 2022-08-15 | 2025-09-17 |
| Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine Spikogen/Covax-19 - COVID-19 | Phase 2 / Phase 3 | Unknown | Vaxine Pty Ltd | 200 | 2022-03-01 | 2024-08-07 |
| Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant - COVID-19 | Phase 3 | Completed | Cinnagen | 581 | 2022-02-23 | 2022-10-17 |
| Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline placebo - COVID-19 | Phase 3 | Completed | Cinnagen | 300 | 2021-12-15 | 2022-10-14 |
| Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen) SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline placebo - Covid19 | Phase 3 | Completed | Cinnagen | 16876 | 2021-08-07 | 2022-10-13 |
COVID-19 (6) · Coronavirus Infections (2)
SARS-CoV-2 recombinant spike protein with delta inulin and CpG-ODN adjuvant vaccine (6) · Saline Solution (1)
Australia (3) · Iran (3)
Payam Tabarsi, M.D. (3) · Dimitar Sajkov, MBBS (1) · Dimitar Sajkov, MD, PhD (1) · Dimitar Sajkov, MD/PhD (1) · Nikolai Petrovsky, MD/PhD (1)